达格列净(BMS-512148) 是用于治疗2型糖尿病的钠-葡萄糖共转运蛋白2 (SGLT2)抑制剂，是格列沙星类药物。
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-propane-1,2-diol hydrate
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
5-Bromo-2-chlorobenzoic acid
(2R,3R,4S,5R,6R)-2-Bromo-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-3,4,5-triyl tris(2,2-dimethylpropanoate)
Ethoxybenzene
(1R,2S,3S,4R,5R)-6,8-Dioxabicyclo[3.2.1]octane-2,3,4-triol
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-delta-lactone
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
(3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
1,2,3,4,6-Penta-o-pivaloyl-d-glucopyranoside
